Skip to main content

DG HEALTH COUGH AND CHEST CONGESTION

NDC 55910-774 · Dolgencorp Inc

Generic namedextromethorphan hydrobromide, guaifenesin
Dosage formSOLUTION
RouteORAL
Active ingredient(s)DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN
Strength10; 200 mg/15mL; mg/15mL
Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
Marketing categoryOTC MONOGRAPH DRUG

Packages

55910-774-40 — 355 mL in 1 BOTTLE (55910-774-40)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

55910-709 — Dextromethorphan HBr, Doxylamine succinate, 55910-716 — Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine HCI, 55910-732 — Guaifenesin, 55910-733 — Guaifenesin, Dextromethorphan HBr, 55910-737 — acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl, 55910-739 — Guaifenesin, 55910-746 — dextromethorphan hydrobromide, guaifenesin, 55910-753 — acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, 55910-755 — Dextromethorphan HBr, Guaifenesin, 55910-757 — Acetaminophen, Guaifenesin, Phenylephrine HCL, 55910-776 — dextromethorphan hydrobromide, guaifenesin, 55910-801 — ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL, 55910-886 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 55910-887 — guaifenesin, 55910-900 — Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl, 55910-904 — guaifenesin, 55910-910 — Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, 55910-927 — Acetaminophen, Guaifenesin, Phenylephrine HCl, 55910-928 — acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride, 55910-958 — dextromethorphan polistirex, +2508 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels